The psychedelic drugs LSD and psilocybin activate serotonin receptors on brain cells in a way that reduces the energy needed for the brain to switch between different activity states, according to a study led by Weill Cornell Medicine researchers.
Read moreMicrodosing- Panacea or Placebo?
Is it all hype or is there genuine hope for therapeutic application of microdosing?
There’s certainly plenty of ‘conflicting’ information or results available from studies of different methodologies. Here, we begin with an overview of what microdosing is, who does it, and for what purposes. We then review available evidence and summarize benefits and risks of microdosing. Finally, we get more practical and discuss microdosing regimens, measurement of accurate dosing, and ‘set and setting’ consideration to microdosing.
from Ben Malcolm, Spirit Pharmacist
Psilocybin for Alcohol Addiction
In a study published Wednesday in JAMA Psychiatry, scientists found that patients taking this drug, called psilocybin, had an 83 percent decline in heavy drinking, while those who took a placebo experienced a 51 percent decline.
Read morePsychedelics for Depression
Here’s the latest on how psychedelics may help treat depression.
Read morePsilocybin for Late-Stage Cancer
CU Cancer Center researchers are collaborating on NCI-funded research to understand the effects of psilocybin on the depression and anxiety that people with cancer can feel.
Read moreNew Psychedelic Research- Interview with a Psychiatrist
Check out this great interview with the latest research on MDMA, psilocybin, and the interaction of psychiatric medications.
Read moreHow Psilocybin May Rewire the Brain
“One of the most interesting things we’ve learned about the classic psychedelics is that they have a dramatic effect on the way brain systems synchronize, or move and groove together,” said Matthew Johnson, a professor in psychedelics and consciousness at Johns Hopkins Medicine.
“When someone’s on psilocybin, we see an overall increase in connectivity between areas of the brain that don’t normally communicate well,” Johnson said. “You also see the opposite of that – local networks in the brain that normally interact with each other quite a bit suddenly communicate less.”
Read moreMore Psilocybin Research
A recent follow-up study by Johns Hopkins Medicine researchers found two doses of the hallucinogenic compound coupled with psychotherapy resulted in large decreases in major depressive disorder symptoms for most of the study’s participants.
New research is hinting at how the hallucinogenic compound may facilitate reduced depression symptoms.
Read morePsilocybin Microdosing -New Research
Psilocybin for Depression Is Effective for One Year
New research shows that psilocybin treatment for major depression is effective for up to a year for most patients.
Read moreSSRI Drugs and Psilocybin
A new study suggests that SSRI drugs can be used safely with psilocybin to treat depression. Keep reading to learn more.
Read more